Michael NL - Search Results

1

Risk factors for HIV-1 infection in a longitudinal, prospective cohort of adults from the Mbeya Region, Tanzania.

Geis S, Maboko L, Saathoff E, Hoffmann O, Geldmacher C, Mmbando D, Samky E, Michael NL, Birx DL, Robb ML, Hoelscher M. Geis S, et al. Among authors: michael nl. J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):453-9. doi: 10.1097/QAI.0b013e3182118fa3. J Acquir Immune Defic Syndr. 2011. PMID: 21297483 Free PMC article.

2

HIV neutralization assay using polymerase chain reaction-derived molecular signals.

Robb ML, Polonis V, Vahey M, Gartner S, Michael N, Fowler A, Redfield RR. Robb ML, et al. J Acquir Immune Defic Syndr (1988). 1992 Dec;5(12):1224-9. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1453333

3

Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression.

Michael NL, Chang G, d'Arcy LA, Tseng CJ, Birx DL, Sheppard HW. Michael NL, et al. J Virol. 1995 Nov;69(11):6758-69. doi: 10.1128/JVI.69.11.6758-6769.1995. J Virol. 1995. PMID: 7474087 Free PMC article.

4

Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell function.

McDonald RA, Mayers DL, Chung RC, Wagner KF, Ratto-Kim S, Birx DL, Michael NL. McDonald RA, et al. Among authors: michael nl. J Virol. 1997 Mar;71(3):1871-9. doi: 10.1128/JVI.71.3.1871-1879.1997. J Virol. 1997. PMID: 9032317 Free PMC article.

5

The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression.

Michael NL, Chang G, Louie LG, Mascola JR, Dondero D, Birx DL, Sheppard HW. Michael NL, et al. Nat Med. 1997 Mar;3(3):338-40. doi: 10.1038/nm0397-338. Nat Med. 1997. PMID: 9055864

6

Dynamics of cell-free viral burden in HIV-1-infected patients.

Michael NL, Chang G, Kim JH, Birx DL. Michael NL, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Mar 1;14(3):237-42. doi: 10.1097/00042560-199703010-00007. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9117456

7

Comparison of serum and plasma viral RNA measurements in primary and chronic human immunodeficiency virus type 1 infection.

Rodriguez RJ, Dayhoff DE, Chang G, Cassol SA, Birx DL, Artenstein AW, Michael NL. Rodriguez RJ, et al. Among authors: michael nl. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 May 1;15(1):49-53. doi: 10.1097/00042560-199705010-00008. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9215654

8

Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infection.

Loomis-Price LD, Cox JH, Mascola JR, VanCott TC, Michael NL, Fouts TR, Redfield RR, Robb ML, Wahren B, Sheppard HW, Birx DL. Loomis-Price LD, et al. Among authors: michael nl. J Infect Dis. 1998 Nov;178(5):1306-16. doi: 10.1086/314436. J Infect Dis. 1998. PMID: 9780250

9

Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells.

Frankel SS, Steinman RM, Michael NL, Kim SR, Bhardwaj N, Pope M, Louder MK, Ehrenberg PK, Parren PW, Burton DR, Katinger H, VanCott TC, Robb ML, Birx DL, Mascola JR. Frankel SS, et al. Among authors: michael nl. J Virol. 1998 Dec;72(12):9788-94. doi: 10.1128/JVI.72.12.9788-9794.1998. J Virol. 1998. PMID: 9811714 Free PMC article.

10

Correlation of tumor suppressor P53 RNA expression with human immunodeficiency virus disease in rapid and slow progressors.

McLinden RJ, Lewis B, Michael NL, Redfield RR, Birx DL, Kim JH. McLinden RJ, et al. Among authors: michael nl. J Hum Virol. 1997 Nov-Dec;1(1):30-6. J Hum Virol. 1997. PMID: 10195228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

463 results

Search Page

Filters